These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14608868)

  • 61. Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization.
    Fagotto F; Jho Eh; Zeng L; Kurth T; Joos T; Kaufmann C; Costantini F
    J Cell Biol; 1999 May; 145(4):741-56. PubMed ID: 10330403
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Roles of beta-catenin overexpression and adenomatous polyposis coli mutation in head and neck cancer].
    Takei S; Ueno Y; Yoda J; Tamura S; Hotomi M; Fujihara K; Kuki K; Yamanaka N
    Nihon Jibiinkoka Gakkai Kaiho; 2003 Jun; 106(6):692-9. PubMed ID: 12872724
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of WNT-1 on beta-catenin expression and its relation to Ki-67 and tumor differentiation in oral squamous cell carcinoma.
    Zhang WM; Lo Muzio L; Rubini C; Yan G
    Oncol Rep; 2005 Jun; 13(6):1095-9. PubMed ID: 15870927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. beta-catenin expression and mutational analysis in renal cell carcinomas.
    Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
    Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients.
    El-Bahrawy MA; Talbot IC; Poulsom R; Jeffery R; Alison MR
    J Pathol; 2002 Sep; 198(1):69-76. PubMed ID: 12210065
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
    Kolligs FT; Bommer G; Göke B
    Digestion; 2002; 66(3):131-44. PubMed ID: 12481159
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Abnormalities of the APC/beta-catenin pathway in endometrial cancer.
    Moreno-Bueno G; Hardisson D; Sánchez C; Sarrió D; Cassia R; García-Rostán G; Prat J; Guo M; Herman JG; Matías-Guiu X; Esteller M; Palacios J
    Oncogene; 2002 Nov; 21(52):7981-90. PubMed ID: 12439748
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell adhesion and signal transduction in cancer. Conference on cadherins, catenins and cancer.
    Birchmeier W
    EMBO Rep; 2005 May; 6(5):413-7. PubMed ID: 15864290
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A beta-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of beta-catenin germline mutations in FAP patients.
    Müller O; Nimmrich I; Finke U; Friedl W; Hoffmann I
    Genes Chromosomes Cancer; 1998 May; 22(1):37-41. PubMed ID: 9591632
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Is Wilms tumor a candidate neoplasia for treatment with WNT/β-catenin pathway modulators?--A report from the renal tumors biology-driven drug development workshop.
    Perotti D; Hohenstein P; Bongarzone I; Maschietto M; Weeks M; Radice P; Pritchard-Jones K
    Mol Cancer Ther; 2013 Dec; 12(12):2619-27. PubMed ID: 24258344
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cadherins in skeletal muscle development.
    Waibler Z; Starzinski-Powitz A
    Results Probl Cell Differ; 2002; 38():187-98. PubMed ID: 12132395
    [No Abstract]   [Full Text] [Related]  

  • 73. Tumor Suppressive Role of MUC6 in Wilms Tumor
    Liu BH; Liu GB; Zhang BB; Shen J; Xie LL; Liu XQ; Yao W; Dong R; Bi YL; Dong KR
    Front Oncol; 2022; 12():756117. PubMed ID: 35574418
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Documentation of Wilms Tumor Histologic Presentation in a Statewide Cancer Registry: Importance to Prognostic Assessment.
    Whiteside M
    J Registry Manag; 2020; 47(2):88-89. PubMed ID: 35363678
    [No Abstract]   [Full Text] [Related]  

  • 75. [Adhesion molecules in Wilm's tumor: expression and significance of beta-catenin (part II)].
    Basta-Jovanović G; Radojević S; Djuricić S; Savin M; Skodrić S; Bunjevacki G; Hadzi-Djokić J; Nesić V
    Srp Arh Celok Lek; 2003; 131(1-2):73-6. PubMed ID: 14608868
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of beta catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy.
    Ramburan A; Oladiran F; Smith C; Hadley GP; Govender D
    J Clin Pathol; 2005 Jan; 58(1):44-50. PubMed ID: 15623481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
    Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
    Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Adhesion molecules in Wilm's tumor (part I)].
    Basta-Jovanović G; Radojević S; Djuricić S
    Srp Arh Celok Lek; 2003; 131(1-2):69-72. PubMed ID: 14608867
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Wnt/beta-catenin pathway in Wilms tumors and prostate cancers.
    Tycko B; Li CM; Buttyan R
    Curr Mol Med; 2007 Aug; 7(5):479-89. PubMed ID: 17691963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.